Skip Nav Destination
Recurrent BTK and PLCG2 Mutations Confer Ibrutinib Resistance
Cancer Discov (2014) 4 (8): 866.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- John Schomberg
Cancer Informatics (2019) 18
RSS Feeds